April 16 – 18 Boston, Massachusetts
Stop by booth #328 to learn more about the following products:
Newly released D360 v19.1
Certara’s self-service integrated platform has expanded its capabilities for biologics scientists, deepened support for small molecule chemistry and added workflow enhancements.
Stop by to see a demo and speak with Dr. David Lowis, Certara D360 Senior Director of Product Management to learn more about these transformative enhancements.
A new version of Certara’s 21 CFR Part 11 compliant PK/PD data repository with significantly enhanced functionality. Attend a lunch presentation to learn more about this exciting new product launching soon!
- Topic: Certara Integral: Next Generation Data Repository
- Track: Software Applications & Services
- Date: Wednesday, April 17th @ 1:10-1:40 PM
- Presenter: Kevin Trimm, Certara Senior Director of Product Strategy
A successful drug development program relies on data being centralized in an accessible, understandable, mineable, traceable, and secure location for analysis and interpretation. Provisioning data to scientists in an organized manner with high performance can be a challenge. Certara Integral is a validated and 21 CFR Part 11 compliant software as a service data and model repository utilizing the CDISC data model and Amazon Web Services Infrastructure, providing an intuitive solution to this problem.
About Our Speaker
Kevin Trimm is the Senior Director of Product Strategy and Services at Certara. Prior to joining Certara as the Director of Phoenix Technology Services, Kevin worked for 14 years in pharmaceutical research. The majority of that time was spent at Charles River Laboratories, where he was the global head of the Pharmacokinetics and Statistics departments. During his tenure at Charles River, Kevin achieved significant growth in these departments through the design, validation, and deployment of both internally developed and commercial software products to introduce efficiency and quality to these scientific services. Kevin later co-founded Montreal Pharmacokinetics Inc., a GLP accredited contract research organization specializing in pharmacokinetic analysis, reporting and consultation that was acquired by Certara in 2018.